These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8294675)

  • 1. Insurance issues and new treatments.
    Neels K
    J Am Dent Assoc; 1994 Jan; 125 Suppl():45S-53S. PubMed ID: 8294675
    [No Abstract]   [Full Text] [Related]  

  • 2. Cost sharing, caps on benefits, and the chronically ill--a policy mismatch.
    Thorpe KE
    N Engl J Med; 2006 Jun; 354(22):2385-6. PubMed ID: 16738277
    [No Abstract]   [Full Text] [Related]  

  • 3. Unintended effects of a cost-containment policy: results of a natural experiment in Germany.
    Schöffski O; Graf von der Schulenburg JM
    Soc Sci Med; 1997 Nov; 45(10):1537-9. PubMed ID: 9351143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential future elements of dental care financing--a third-party payer's perspective.
    Manos PA; Bramson JB
    J Calif Dent Assoc; 2013 Dec; 41(12):887-94. PubMed ID: 24597016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prescription drug and dental programs.
    Sutton HL
    Empl Benefits J; 1986 Jun; 11(2):20-6. PubMed ID: 10277061
    [No Abstract]   [Full Text] [Related]  

  • 6. Economic constraints and prescribing patterns in New Zealand.
    Kellaway GS
    Pharmacoeconomics; 1992 Sep; 2(3):189-97. PubMed ID: 10147009
    [No Abstract]   [Full Text] [Related]  

  • 7. The costs of making practice more cost-effective.
    Weeks WB; Wallace AE
    JAMA; 2002 Apr; 287(13):1648; author reply 1649-50. PubMed ID: 11926883
    [No Abstract]   [Full Text] [Related]  

  • 8. Current trends in dental benefit plans. Perspectives on costs of employer-sponsored plans.
    Arison P
    Ont Dent; 1996 Sep; 73(7):35-7. PubMed ID: 9470629
    [No Abstract]   [Full Text] [Related]  

  • 9. The future of direct reimbursement plans.
    Heidenreich EJ
    Dent Econ; 1992 Jan; 82(1):16, 19-20. PubMed ID: 1499779
    [No Abstract]   [Full Text] [Related]  

  • 10. A randomized experiment of the effects of including alternative medicine in the mandatory benefit package of health insurance funds in Switzerland.
    Sommer JH; Bürgi M; Theiss R
    Complement Ther Med; 1999 Jun; 7(2):54-61. PubMed ID: 10444908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third party contracting and buying groups across the United States.
    Strandberg LR; Richardson R; Fenerin M
    Am Pharm; 1986 Jul; NS26(7):42-4. PubMed ID: 3751884
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaceutical Benefits Scheme.
    Louis WJ; O'Callaghan CJ; Krum H; Mander AG; Louis ES
    Med J Aust; 1994 Jul; 161(2):174. PubMed ID: 8028551
    [No Abstract]   [Full Text] [Related]  

  • 13. Dental insurance and prepayment plans: today and tomorrow.
    Ziegler EF
    Northwest Dent; 1982; 61(6):9-11. PubMed ID: 6963399
    [No Abstract]   [Full Text] [Related]  

  • 14. Dental insurance: will it help or hinder adoption of caries management practices?
    Anderson MH
    J Dent Educ; 2007 May; 71(5):592-4. PubMed ID: 17493967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pricing and reimbursement of pharmaceuticals.
    Towse A
    Pharmacoeconomics; 1994; 6 Suppl 1():36-8. PubMed ID: 10155584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do drug copayments work?
    David J
    CMAJ; 1994 May; 150(9):1491-3. PubMed ID: 8168015
    [No Abstract]   [Full Text] [Related]  

  • 17. The pills that ate your profits.
    Meyer H
    Hosp Health Netw; 1998 Feb; 72(3):18-22. PubMed ID: 9483145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends and determinants of prescription drug expenditures in the elderly: data from the British Columbia Pharmacare Program.
    Anderson GM; Kerluke KJ; Pulcins IR; Hertzman C; Barer ML
    Inquiry; 1993; 30(2):199-207. PubMed ID: 8314608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prescription patterns. Where the medicine goes down.
    Haugh R
    Hosp Health Netw; 1998 Jul; 72(14):39. PubMed ID: 9714587
    [No Abstract]   [Full Text] [Related]  

  • 20. Acceptable incremental cost effectiveness ratio for use of new drugs, cases in statin therapies.
    Nakao S; Kawabe H; Takuma H; Shiragami M
    Yakugaku Zasshi; 2010 Oct; 130(10):1347-52. PubMed ID: 20930487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.